Chromatography

Assessment of the Chromatography Resin Industry, 2023-2028 Featuring Profiles of Key Players Including Bio-Rad Labs, Merck, Danaher, Tosoh, Sartorius Stedim Biotech - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 29, 2023
Biotechnology, Manufacturing, Health, Pharmaceutical, Chemicals, Plastics, FNB, GC/MS, Drink, Tosoh, Mitsubishi Chemical Corporation, Ligand, Medication, Chromatography, Merck Group, Research, Antibody, USD, Danaher Corporation, Ion exchange, Organization, Nature, Quality control, Growth, A-DNA, Food, World Health Organization, Fine chemical

This comprehensive report meticulously dissects the chromatography resin market, delving into its categorization by type, technique, application, and region, offering size predictions across diverse geographic areas.

Key Points: 
  • This comprehensive report meticulously dissects the chromatography resin market, delving into its categorization by type, technique, application, and region, offering size predictions across diverse geographic areas.
  • Chromatography has emerged as a prominent analytical technique for assessing the quality of processed food products and diverse beverages.
  • This increasing recognition of accurate analytical methods is a key driver behind the growth of the chromatography resin market.
  • Various types of synthetic or manmade polymers, including polyacrylamide, polymethacrylate, and polystyrene, serve as essential media in diverse chromatography applications.

Global Cell and Gene Therapy Manufacturing QC Market Expected to Reach $10.65 Billion by 2033, Witnessing a CAGR of 16.85% - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 16, 2023
Biotechnology, Genetics, Health, Gene, QC, NGS, Sartorius AG, Chromatography, Merck Group, MEA, Medicine, Research, Mass spectrometry, ELISA, Organization, Information International, Inc., CAR, QRM, Thermo Fisher Scientific, Patient safety, Flow cytometry, Kidney, Cell, PAT, LAL, Center for Urban and Regional Analysis, Electrophoresis, Therapy, Benchmarking, Eurofins Scientific, PCR, Safety, Automation, LATAM, Fine chemical, Pharmaceutical industry

The "Cell and Gene Therapy Manufacturing QC Market - A Global and Regional Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cell and Gene Therapy Manufacturing QC Market - A Global and Regional Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.
  • The global cell and gene therapy manufacturing QC market was valued at $1.95 billion in 2022 and is projected to reach $10.65 billion by 2033, with a CAGR of 16.85% during the forecast period from 2023 to 2033.
  • The demand for QC in cell and gene therapy manufacturing is driven by the growing production of therapies and increasing approvals for cell and gene therapies.
  • The global cell and gene therapy manufacturing QC market is on a growth trajectory, and key players are leveraging advancements in technology to drive improvements in product quality and safety.

Prodigy Processing Solutions Unveils Groundbreaking Cannabis Extraction Technology

Retrieved on: 
Tuesday, August 15, 2023
Cannabis, Prodigy, CRN, Chromatography, EU, ROI, GC, CRC, Workflow, PROX, Safety, Conveyor system

MIAMI, Aug. 15, 2023 /PRNewswire/ -- Prodigy Processing Solutions ("Prodigy"), a trailblazer in the cannabis and hemp extraction industry, today unveiled its flagship product, the ProX, representing an unparalleled leap forward in extraction technology.

Key Points: 
  • MIAMI, Aug. 15, 2023 /PRNewswire/ -- Prodigy Processing Solutions ("Prodigy"), a trailblazer in the cannabis and hemp extraction industry, today unveiled its flagship product, the ProX, representing an unparalleled leap forward in extraction technology.
  • Founded by Marc Beginin, a seasoned cannabis extraction entrepreneur, Prodigy Processing Solutions strives to deliver high-quality and industry-altering extraction methods.
  • Next-generation technology: Representing the next evolution in cannabis extraction, the ProX provides unprecedented performance by exceeding expectations, dominating competitive products and delivering maximum ROI for its customers.
  • "With the ProX, the Prodigy team has gone above and beyond traditional design paradigms," said Marc Beginin, CEO of Prodigy Processing Solutions.

Global Process Instrumentation Market Insights for 2023 - Driving Efficiency and Quality - ResearchAndMarkets.com

Retrieved on: 
Friday, August 11, 2023
Other Manufacturing, Engineering, Transport, Chemicals, Plastics, Oil, Gas, Manufacturing, Energy, Logistics, Supply Chain Management, Retail, Workforce, Semiconductor, Pais, Food, QC, Face, Biotechnology, COVID-19, Chromatography, Research, Investment, PAI, Growth, Safety, Medical device

Their primary goal is to ensure process safety, optimize operations, and maintain product quality.

Key Points: 
  • Their primary goal is to ensure process safety, optimize operations, and maintain product quality.
  • This will negatively impact both the workforce and the demand for process analytical instruments, particularly as the manufacturing sector contracts.
  • The process analytical instrument market in this report includes process electrochemistry, spectroscopy, chromatography, and other products.
  • Market demand segmented by technique, region, sector, and industry along with yearly market forecasts through 2027.

Global Life Science Instrumentation Market Report 2023: Sector is Expected to Reach $107.3 Billion by 2030 at a CAGR of 6.5% - ResearchAndMarkets.com

Retrieved on: 
Friday, June 16, 2023
Biotechnology, Pharmaceutical, Health, Medical Devices, Vaccine, Prevalence, Software, Coalition, NGS, Chromatography, Diagnosis, Food quality, MEA, Research, Mass spectrometry, World Bank, USD, Government, Market, Agilent Technologies, Flow cytometry, Hospital, Laboratory, Application, Machine learning, Engineering, Plant growth analysis, Artificial intelligence, Conditional sentence, Virtual Control, Growth, AI, Microscopy, NYSE, PCR, Third-generation sequencing, Management, Medical device, Fine chemical, Health care, Electrophoresis

The global life science instrumentation market refers to the market for various analytical instruments, devices, and equipment used in the field of life sciences.

Key Points: 
  • The global life science instrumentation market refers to the market for various analytical instruments, devices, and equipment used in the field of life sciences.
  • Global life science instrumentation market is segmented based on technology, application, distribution channel and region.
  • Based on the application, the global life science instrumentation market is segmented into Clinical and Diagnostic, Research and Others.
  • The growth of the life science instrumentation market is being propelled by several factors including increased government spending in life science research and development in the biotechnology and life science sectors.

Hamilton Offers In-Depth Exploration of DSP Operation Units and CPPs with New White Paper

Retrieved on: 
Thursday, June 15, 2023
GMP, Virus inactivation, IEX, Filtration, CQA, Chromatography, PAT, Safety, Environment, DSP, Fine chemical

BONADUZ, Switzerland, June 15, 2023 /PRNewswire/ -- Hamilton has just released a comprehensive new white paper, "Biopharma PAT: Downstream Critical Process Parameters."

Key Points: 
  • BONADUZ, Switzerland, June 15, 2023 /PRNewswire/ -- Hamilton has just released a comprehensive new white paper, "Biopharma PAT: Downstream Critical Process Parameters."
  • This whitepaper serves as a powerful resource for biopharma manufacturers seeking to design efficient and robust DSP processes and ensure product quality, safety, and efficacy in biopharmaceutical production.
  • The document is compelling for downstream skid-builders as well with multiple real-life examples provided.
  • In this white paper, Hamilton explores the CPPs which are mandatory to control for each unit operation of the DSP skid train, such as: buffer preparation/dilution, protein A and IEX chromatography, filtration, and virus inactivation.

Cannabix’s MSBS Marijuana Breathalyzer Technology Detects THC in Breath after Edibles Consumption

Retrieved on: 
Wednesday, June 14, 2023
Edible, Food, CSE, Metabolism, Chromatography, MSBS, Capsule, Candy, LCMS, Collection, OTC, BCU, Liver, Cannabis, THC, Smoking, Personal protective equipment, Figure

Cannabix’s Mass Spectrometer Breath Sampler (“MSBS”) technology along with the handheld Breath Collection Unit (“BCU”) have been providing consistent results in the detection of THC in breath from smoking.

Key Points: 
  • Cannabix’s Mass Spectrometer Breath Sampler (“MSBS”) technology along with the handheld Breath Collection Unit (“BCU”) have been providing consistent results in the detection of THC in breath from smoking.
  • More recently, the technology has been used to detect THC after consumption of edibles containing marijuana.
  • MSBS technology has shown the sensitivity in the low picogram range, for THC in breath allowing for detection of THC from smoking and edibles up to 4 hours after consumption.
  • Cannabix’s MSBS method for detection of THC in breath has striking differences with conventional, legacy methods [1].

Seer Collaborates to Make Scalable, Unbiased Proteomics Accessible to More Researchers via new Seer Technology Access Center

Retrieved on: 
Wednesday, June 7, 2023
Astral, Proteogenomics, Workflow, Mass spectrometry, Chromatography, Cancer, Proteome, Thermo Fisher Scientific, Genomics, Proteomics, Science, Plasma, Thermo, Area studies, Seer, IDS, SEER, Health, Disease, Orbitrap, Heating, ventilation, and air conditioning, Uranium mining

As part of the collaboration, Seer will establish the Seer Technology Access Center to showcase its latest product, the Proteograph XT Assay Kit, in combination with Thermo Fisher’s newest mass spectrometer, the Thermo Scientific™ Orbitrap™ Astral™ mass spectrometer (MS).

Key Points: 
  • As part of the collaboration, Seer will establish the Seer Technology Access Center to showcase its latest product, the Proteograph XT Assay Kit, in combination with Thermo Fisher’s newest mass spectrometer, the Thermo Scientific™ Orbitrap™ Astral™ mass spectrometer (MS).
  • The Seer Technology Access Center will address an important unmet need for researchers who do not have access to mass spectrometry, but wish to undertake deep unbiased proteomics studies, such as translational and genomics researchers performing population-scale studies with deep molecular profiling.
  • As part of the collaboration, Seer and Thermo Fisher will develop and optimize proteomics and proteogenomics workflows, including the integration of data and analysis protocols.
  • To learn more about Seer’s Technology Access Center, contact your local Seer representative by requesting a consultation at www.seer.bio.

Purolite Grows Bioprocessing Production Capacity with New U.S. Manufacturing Facility

Retrieved on: 
Tuesday, June 6, 2023
Other Manufacturing, Commercial Building & Real Estate, Construction & Property, Chemicals, Plastics, Building Systems, Manufacturing, Biotechnology, Pharmaceutical, Health, Other Construction & Property, Inc., Therapy, Senior, Chromatography, Messenger, Hygiene, Patient, Laboratory, Investment, Ecolab, Growth, Commonwealth, Pharmaceutical industry, Fine chemical

The expansion plans for the new U.S. location include the construction of resin production facilities, cleanrooms, laboratories and new office space.

Key Points: 
  • The expansion plans for the new U.S. location include the construction of resin production facilities, cleanrooms, laboratories and new office space.
  • Additional land is available at the site for future expansion to meet potential growth needs of the Purolite business.
  • Once completed, the new facility is expected to significantly expand production capacity and add more than 150 skilled jobs in the next five years.
  • The expanded production capacity will allow Purolite to better support innovators worldwide with premier purification resin that will increase yield, optimize productivity and reduce the time needed to bring lifesaving therapeutics to market.

RedShift BioAnalytics Launches HaLCon™ Analyzer, Providing Simple and Accurate On-Demand Protein Titer Measurements for Bioprocess Development and Manufacturing

Retrieved on: 
Wednesday, June 7, 2023
Redshift, LC, Monolithic HPLC column, Chromatography, Analyser, Bioreactor, HPLC, Fine chemical

BOXBOROUGH, Mass. , June 7, 2023 /PRNewswire/ -- RedShift BioAnalytics (RedShiftBioⓇ) today announced it was launching the HaLCon Analyzer, an advanced, fit-for-purpose, liquid chromatography platform designed to provide protein titer results equivalent to traditional protein A, HPLC with a faster, easier, and more cost-effective platform method. The HaLCon Analyzer integrates seamlessly into any bioprocessing suite without disrupting existing workflows or equipment and requires no chromatography expertise.

Key Points: 
  • RedShiftBio introduces the HaLCon Protein Analyzer, the first fit-for-purpose liquid chromatography (LC) system designed specifically to provide quick, easy, and accurate protein titer measurements for biopharmaceutical development and manufacturing.
  • , June 7, 2023 /PRNewswire/ -- RedShift BioAnalytics (RedShiftBioⓇ) today announced it was launching the HaLCon Analyzer, an advanced, fit-for-purpose, liquid chromatography platform designed to provide protein titer results equivalent to traditional protein A, HPLC with a faster, easier, and more cost-effective platform method.
  • New HaLCon liquid chromatography system provides fast, easy protein titer for biopharma development and manufacturing.
  • Now, users without chromatography experience can get extremely accurate titer measurements on-line or at-line in minutes, generating actionable results and optimizing the utilization of the bioreactors.